Incidence of Atypical Change and Risk of Breast Cancer in Patients with Gynecomastia

Shaaban AM. Pathology of the male breast. Diagn Histopathol. 2019;25(4):138-42. doi: 10.1016/j.mpdhp.2019.01.004.

Hamady ZZ, Carder PJ, Brennan TG. Atypical ductal hyperplasia in male breast tissue with gynaecomastia. Histopathology. 2005;47(1):111-2. doi: 10.1111/j.1365-2559.2005.02042.x. [PubMed: 15982330].

Rahmani S, Turton P, Shaaban A, Dall B. Overview of gynecomastia in the modern era and the leeds gynaecomastia investigation algorithm. Breast J. 2011;17(3):246-55. doi: 10.1111/j.1524-4741.2011.01080.x. [PubMed: 21477170]

Al-Allak A, Govindarajulu S, Shere M, Ibrahim N, Sahu AK, Cawthorn SJ. Gynaecomastia: a decade of experience. Surgeon. 2011;9(5):255-8. doi: 10.1016/j.surge.2010.10.004. [PubMed: 21843819].

Alali L, Honarpisheh H, Shaaban A, Speirs V. Conditions of the male breast: Gynaecomastia and male breast cancer (Review). Mol Med Rep. 2010;3(1):21-6. doi: 10.3892/mmr_00000213. [PubMed: 21472195].

Narula HS, Carlson HE. Gynaecomastia—pathophysiology, diagnosis and treatment. Nat. Rev Endocrinol. 2014;10(11):684-98. doi: 10.1038/nrendo.2014.139. [PubMed: 25112235].

Fagerlund A, Lewin R, Rufolo G, Elander A, Santanelli di Pompeo F, Selvaggi G. Gynecomastia: A systematic review. J Plast Surg Hand Surg. 2015;49(6):311-8. doi: 10.3109/2000656X.2015.1053398. [PubMed: 26051284].

Reisenbichler E, Hanley KZ. Developmental disorders and malformations of the breast. Semin Diagn Pathol. 2019;36(1):11-5. doi: 10.1053/j.semdp.2018.11.007. [PubMed: 30503250].

Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65(3):518-29. doi: 10.1002/1097-0142(19900201)65:3<518::aid-cncr2820650324>3.0.co;2-o. [PubMed: 2297643].

Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698-708. doi: 10.1002/1097-0142(19850601)55:11<2698:: aid-cncr2820551127>3.0.co;2-a. [PubMed: 2986821].

Ferzoco RM, Ruddy KJ. The Epidemiology of Male Breast Cancer. Curr Oncol Rep. 2016;18(1):1-6. doi: 10.1007/s11912-015-0487-4. [PubMed: 26694922].

Coopey SB, Kartal K, Li C, Yala A, Barzilay R, Faulkner HR, et al. Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk? Breast Cancer Res Treat. 2019;175(1):1-4. doi: 10.1007/s10549-018-05117-4. [PubMed: 30666539].

Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(1):20-6. [PubMed: 15668471].

Wells JM, Liu Y, Ginter PS, Nguyen MT, Shin SJ. Elucidating encounters of atypical ductal hyperplasia arising in gynaecomastia. Histopathology. 2015;66(3):398-408. doi: 10.1111/his.12545. [PubMed: 25215584]

Bannayan GA, Hajdu SI. Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol. 1972;57(4):431-37. doi: 10.1093/ajcp/57.4.431. [PubMed: 5012934].

Senger JL, Chandran G, Kanthan R. Is routine pathological evaluation of tissue from gynecomastia necessary? A 15-year retrospective pathological and literature review. Plast Surg. 2014;22(2):112-6. [PubMed: 25114624]

Andersen JA, Gram JB. Male breast at autopsy. Acta Pathol Microbiol Immunol Scand A. 1982;90(3):191-7. doi: 10.1111/j.1699-0463.1982.tb00081_90a.x. [PubMed: 6285667].

Cole FM, Qizilbash AH. Carcinoma in situ of the male breast. J Clin Pathol. 1979;32(11):1128-34. doi: 10.1136/jcp.32.11.1128. [PubMed: 229125].

Lapid O, Jolink F, Meijer SL. Pathological findings in gynecomastia: analysis of 5113 breasts. Ann Plast Surg. 2015;74(2):163-6. doi: 10.1097/SAP.0b013e3182920aed. [PubMed: 23788148].

Coyne JD. Gynecomastia with atypical ductal hyperplasia and ductal carcinoma ın situ associated with ınvasive breast carcinoma in a male patient on antiretroviral therapy: a case report. Int J Surg Pathol. 2016;24(2):139-41. doi: 10.1177/1066896915608437. [PubMed: 26612847].

Shirah BH, Shirah HA. Incidental unilateral and bilateral ductal carcinoma in situ encountered in the surgical management of young male gynecomastia. Breast Dis. 2016;36(2-3):103-10. doi: 10.3233/BD-160223. [PubMed: 27612041].

Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367(9510):595-604. doi: 10.1016/S0140-6736(06)68226-3. [PubMed: 16488803].

Niewoehner CB, Schorer AE. Gynaecomastia and breast cancer in men. Bmj. 2008;336(7646):709-13. doi: 10.1136/bmj.39511.493391.BE. [PubMed: 18369226].

Isley LM, Cluver AR, Leddy RJ, Baker MK. Primary sarcoid of the breast with incidental malignancy. J Clin Imaging Sci. 2012;2:1-4. doi: 10.4103/2156-7514.99180. [PubMed: 22919560].

Olsson H, Bladstrom A, Alm P. Male gynecomastia and risk for malignant tumours–a cohort study. BMC cancer. 2002;2(1):1-6. doi: 10.1186/1471-2407-2-26. [PubMed: 12383352].

Kasielska A, Antoszewski B. Surgical management of gynecomastia: an outcome analysis. Ann Plast Surg. 2013;71(5):471-5. doi: 10.1097/SAP.0b013e31824e296a. [PubMed: 23187709].

Koshy JC, Goldberg JS, Wolfswinkel EM, Ge Y, Heller L. Breast cancer incidence in adolescent males undergoing subcutaneous mastectomy for gynecomastia: is pathologic examination justified? A retrospective and literature review. Plast Reconstr Surg. 2011;127(1):1-7. doi: 10.1097/PRS.0b013e3181f9581c. [PubMed: 20871489].

Tavassoli FA, Eusebi V. Tumours of the mammary gland.(Atlas of Tumor Pathology. Series 4). United States: American Registry of Pathology;2009.

Cakan N, Kamat D. Gynecomastia: evaluation and treatment recommendations for primary care providers. Clin Pediatr. 2007;46(6):487-90. doi: 10.1177/0009922806294800. [PubMed: 17579100].

Daniels IR, Layer GT. Gynaecomastia. Eur J Surg. 2001;167(12):885–92. doi: 10.1080/110241501753361550.

留言 (0)

沒有登入
gif